ADIPOQ and obesity disorder: While physiologic levels of insulin and adiponectin activate endothelial nitric oxide synthase (30, 31), that increases nitric oxide (NO), a regulator of vascular tone, insulin resistance and reduced adiponectin in the context of obesity diminish endothelial cell production of NO.